You just read:

Taiwan National Health Insurance Administration of the Ministry of Health and Welfare Approves Vemlidy(R) (tenofovir alafenamide) for Reimbursement

News provided by

Gilead Sciences, Inc.

30 Apr, 2019, 05:33 BST